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Background: Cappuccino is a formin actin nucleator that regulates cytoskeletal organization during Drosophila oogenesis.
Results: Cappuccino binds microtubules through two domains and cannot nucleate actin filaments when bound to
microtubules.
Conclusion: Actin filament assembly and microtubule binding are mutually exclusive activities of Cappuccino.
Significance: We provide mechanistic insight into the role of formins as coordinators of the actin and microtubule
cytoskeletons.
Formin family actin nucleators are potential coordinators of
the actin and microtubule cytoskeletons, as they can both
nucleate actin filaments and bind microtubules in vitro. To
gain a more detailed mechanistic understanding of formin-
microtubule interactions and formin-mediated actin-microtu-
bule cross-talk, we studied microtubule binding by Cappuccino
(Capu), a formin involved in regulating actin and microtubule
organization during Drosophila oogenesis. We found that two
distinct domains within Capu, FH2 and tail, work together to
promote high-affinity microtubule binding. The tail domain
appears to bind microtubules through nonspecific charge-based
interactions. In contrast, distinct residues within the FH2
domain are important for microtubule binding. We also report
the first visualization of a formin polymerizing actin filaments in
the presence of microtubules. Interestingly, microtubules are
potent inhibitors of the actin nucleation activity of Capu but
appear to have little effect on Capu once it is bound to the barbed
end of an elongating filament. Because Capu does not simulta-
neously bind microtubules and assemble actin filaments in vitro,
its actin assembly and microtubule binding activities likely
require spatial and/or temporal regulation within the Drosoph-
ila oocyte.
Coordination of actin and microtubule cytoskeletal networks
is required for a diverse set of cellular processes, from cell
motility and morphogenesis to intracellular transport and
nuclear migration (1, 2). Recently, formin family actin nuclea-
tors have emerged as coordinators of the actin and microtubule
cytoskeletons. In addition to nucleating actin filaments, all
formins tested to date directly bind microtubules in vitro (3, 4).
Although actin polymerization by formins has been well
characterized, how formins coordinate actin and microtubule
networks remains an open question. In fact, only three formins
(mDia1, mDia2, hINF2) representing just two of the 15 meta-
zoan formin groups have been characterized in any biochemical
detail (4), and experimental data for formin-microtubule bind-
ing vary widely across the few formins studied. Several in vitro
experiments suggest that actin and microtubules directly com-
pete for formin binding: for example, microtubules potently
inhibit actin polymerization by mDia2, whereas actin mono-
mers compete with microtubules for binding to hINF2 (4). In
contrast, other findings support a role for formins in the coor-
dination of actin and microtubule networks: overexpression of
mDia1 or FHOD1 aligns actin and microtubule networks in
cells (5, 6), and hINF2 and Cappuccino (Capu)2 can cross-link
actin and microtubules in vitro (4, 7). Although this variety
likely reflects the specialized cellular roles of distinct formins, it
is unclear whether conserved microtubule binding mecha-
nisms exist or whether this functional diversity stems from
fundamental differences in formin-microtubule interactions.
Addressing this question will require careful biochemical anal-
ysis of microtubule binding by a variety of formins representing
the many formin groups.
To further improve our mechanistic understanding of formin-
microtubule interactions and formin-mediated actin-microtubule
cross-talk, we studied microtubule binding by the Drosophila
formin Capu. Capu belongs to the FMN group of formin nuclea-
tors and has two conserved mammalian homologs, Fmn-1 and
Fmn-2 (8). All three proteins are involved in cytoskeletal regu-
lation during key stages of development. Capu is required for
establishing the major body axes of the developing Drosophila
oocyte, and loss of Capu leads to severe polarity defects and
female sterility (9). Similarly, Fmn-1 and Fmn-2 have been
implicated in a variety of developmental processes, including
limb patterning and oocyte spindle positioning (10 –12).
Although these proteins all bind microtubules in vitro (13, 14),
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little else is known about how FMN group formins interact with
microtubules and coordinate the actin and microtubule cyto-
skeletons. The absence of comprehensive mechanistic data for
these and other formins has made it difficult to study the phys-
iological relevance of such formin-microtubule interactions.
In this study, we have characterized Capu-microtubule bind-
ing in detail and examined the relationship between the micro-
tubule binding and actin assembly activities of Capu. We report
that Capu binds microtubules with high affinity, suggesting that
this is a physiologically relevant interaction. Binding requires
distinct residues within the formin homology 2 (FH2) domain
as well as nonspecific charge-based interactions with the C-ter-
minal tail domain of Capu. Additionally, we found that Capu
does not bind microtubules and assemble new actin filaments
simultaneously. Specifically, microtubules are potent inhibitors
of Capu’s actin nucleation activity both in the absence and pres-
ence of profilin, but cannot effectively compete for binding to
Capu that is already bound to the barbed end of an elongating
actin filament. This study provides new mechanistic informa-
tion about formin-microtubule binding and represents the first
detailed biochemical study of microtubule binding by a FMN
group formin. Together with biochemical studies of other
formins, our findings offer insight into the physiological rele-
vance of the formin-microtubule interaction and will help cre-
ate necessary tools for future in vivo work.
EXPERIMENTAL PROCEDURES
DNA Constructs and Capu Mutant Cloning—Wild-type
(amino acids 467–1059), mutant, and truncated CapuCT con-
structs were subcloned into a modified version of pET15b with
an N-terminal His6 tag as described previously (15). The Capu
tail (amino acids 1029 –1059) was subcloned into the vector
pGEX-6P-2 (GE Healthcare) as described (15). Point mutations
were introduced using QuikChange site-directed mutagenesis
(Stratagene).
To identify the D854N point mutation, ovaries were dis-
sected from capu2L-7-13 females (16) in cold ionically matched
adult Drosophila saline buffer (17). RNA was isolated from the
ovaries using the RNeasy Mini Kit (Qiagen) according to the
manufacturer’s instructions for animal tissue samples. cDNA
was generated using the Maxima Universal First Strand cDNA
synthesis kit (Fermentas), subcloned into the vector pJET1.2
(Fermentas), and sequenced (GENEWIZ).
Protein Expression and Purification—Acanthamoeba cas-
tellani actin, chickadee (Chic; Drosophila profilin), and
Schizosaccharomyces pombe profilin were purified according to
published protocols (18, 19). All His6-tagged CapuCT and
CapuFH2 proteins were expressed and purified as described
(15) with the following modifications for CapuFH2: dialysis
buffers were supplemented with 50 mM KCl and storage buffer
contained 100 mM NaCl to improve protein solubility. The
total concentration of protein was calculated by quantitative
Sypro-Red (Invitrogen) staining using wild-type CapuCT as
a standard.
GST and GST-tail were expressed as described (15). Briefly,
extracts were passed over glutathione-Sepharose (GE Health-
care), eluted using glutathione, dialyzed overnight against 10
mM Tris-HCl, pH 8.0, 1 mM DTT, and further purified over a
MonoQ anion exchange column (GE Healthcare).
Microtubule Preparation—Frozen aliquots of tubulin in BRB
buffer (80 mM K-PIPES, pH 6.8, 1 mM EGTA, 1 mM MgCl2)
supplemented with 1 mM GTP were prepared from lyophilized
tubulin (catalog no. T240, Cytoskeleton, Inc.). Tubulin was
thawed quickly at 37 °C, incubated for 5 min on ice, and centri-
fuged at 100,000  g for 10 –20 min at 4 °C. Tubulin concentra-
tion in the supernatant was determined by its absorbance at 280
nm (280  115,000 cm1 M1) and subsequently polymerized
in BRB buffer plus 2 mM GTP at 37 °C by addition of 0.1, 1, and
20 M taxol (paclitaxel, Sigma-Aldrich) at 10-min intervals
from 100-fold concentrated dimethyl sulfoxide stocks.
For experiments with subtilisin-treated microtubules, polymer-
ized tubulin was incubated with 100 g/ml subtilisin (Sigma-Al-
drich) at 37 °C for 1 h. The reaction was quenched with 2 mM
PMSF, and microtubules were spun over a 10% sucrose cushion
at 70,000  g for 10 min at 25 °C to remove cleaved peptides.
The pellet was washed and resuspended in microtubule-bind-
ing buffer (MTB; 10 mM Na-HEPES, pH 7.0, 1 mM EGTA, 1 mM
MgCl2, 1 mM DTT, 20 M taxol, 0.5 mM thesit (nonaethylene
glycol monodecyl ether, P-9641; Sigma-Aldrich) and 50 or 100
mM KCl as indicated).
Microtubule-binding Assays—Microtubule-binding assays
were performed essentially as described (13) with modifica-
tions. Briefly, CapuCT proteins, GST, or GST-tail were cleared
at 100,000  g for 20 min at 4 °C. For actin monomer competi-
tion experiments, actin was preincubated on ice with a 2-fold
molar excess of latrunculin B (LatB; EMD Millipore Chemi-
cals). LatB-actin and Chic samples were each diluted in MTB
and cleared at 100,000  g for 20 min at 4 °C. Protein concen-
tration in the supernatant was determined by absorbance at 280
nm or 290 nm for LatB-actin. Proteins were mixed with micro-
tubules (0.5 M) or buffer in MTB. Samples were incubated for
15 min and centrifuged at 100,000  g for 10 min at 25 °C.
Supernatants were removed, and pellets were washed before
resuspending in SDS-PAGE sample buffer.
Proteins were resolved by SDS-PAGE, stained with Sypro-
Red (Invitrogen), and quantified using a Pharos FX Plus Molec-
ular Imager with Quantity One software (Bio-Rad). Signals
from samples without microtubules were subtracted from the
corresponding signals from samples containing microtubules
to account for nonspecific protein pelleting. Protein and tubu-
lin concentrations in each pellet sample were quantified using a
standard curve for tubulin and the protein in question gener-
ated on the same gel. All concentrations reported are dimer
concentrations of CapuCT, GST, or tubulin.
Binding data were fit to the McGhee von Hippel model for
binding to a polar one-dimensional lattice (20),
Ctotal  MTtotal v 
Kd v
1  nv 1  nv1  n  1v
1  n
(Eq. 1)
where Kd  e  rG/RT.
The binding density v was measured by dividing the concen-
tration of bound protein by the total concentration of poly-
merized tubulin dimers in the pellet (MTtotal). For large Ctotal,
the value of v approaches a maximum value of 1/n where n
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represents the number of tubulin dimers per binding site.
Because we can arbitrarily use the dissociation constant Kd ver-
sus the association constant Ka of the binding reaction, we
instead fit the free energy (rG) of the binding reaction, as this
is unbiased by the direction of the reaction. We then converted
rG to the Kd values reported in Table 1. The fit parameters
rG and n were determined using the Levenberg-Marquardt
algorithm implemented in Python using SciPy software (43).
Pyrene-actin Polymerization Assays—Pyrene-actin assembly
assays were carried out as described (19). For the experiments
in Fig. 2, buffers were supplemented with 20 M taxol from a 10
mM stock in dimethyl sulfoxide. Unless stated otherwise,
microtubules were added to the polymerization buffer before
addition to magnesium-charged monomeric actin. For experi-
ments with profilin, S. pombe profilin was briefly pre-incubated
with monomeric actin and used at a final concentration of 8 M.
Fluorescence was monitored in a spectrofluorometer (Photon
Technology) or a TECAN F200 with excitation  365 nm and
emission  407 nm.
Total Internal Reflection Fluorescence Microscopy—Cover
glass was silanized and functionalized with biotin-PEG as
described (19, 22). Actin was labeled at Cys-374 with Oregon-
Green 488 iodoacetamide (Invitrogen) or EZ-link maleimide-
PEG2-biotin (Thermo Scientific) essentially as described (19).
Because labeling with biotin at Cys-374 caused F-actin to depo-
lymerize, the actin was subsequently centrifuged at 195,000  g,
and the supernatant was further purified by size exclusion chro-
matography on a Superdex 200 10/300 GL (GE Healthcare) in
G-buffer (2 mM Tris-Cl, pH 8.0, 0.1 mM CaCl2, 0.2 mM ATP, 0.5
mM TCEP, 0.04% sodium azide). Biotin-actin could incorporate
into actin filaments at low labeling fractions (2%).
Microtubules were prepared as described above, with the
exception that frozen tubulin aliquots contained 20%
HiLyte647 tubulin (catalog no. TL670M Lot: 013, 	0.2 dyes per
tubulin dimer, Cytoskeleton, Inc.) and 10% biotin tubulin (cat-
alog no. T333P Lot: 013, 	1–2 biotins per tubulin dimer, Cyto-
skeleton, Inc.). F-actin seeds were polymerized from 99.4%
unlabeled actin, 0.6% biotinylated actin, and equimolar Alexa
Fluor 488 phalloidin (Invitrogen). Prior to imaging, 	15-l
flow cells were built using double-stick tape. Each flow cell was
prepared with the following series of washes: 25 l 1% Pluronic-
F127 (Sigma); 100 g/ml -casein (Sigma) in phosphate-buff-
ered saline for 2 min; 25 l of TIRF buffer (KMEH (50 mM KCl,
10 mM Na-HEPES, pH 7.0, 1 mM EGTA, 1 mM MgCl2), 50 mM
DTT, 20 mM glucose, 0.2 mM ATP, 0.2% methylcellulose (400
cP, Sigma)); 25 l of 40 nM streptavidin (VWR) in KMEH for 1
min; 25 l of TIRF buffer supplemented with 20 M taxol, 25 l
of 5–50 nM F-actin seeds, and 	0.5 M taxol-stabilized micro-
tubules in KMEH with 40 M taxol for 2 min; and 25 l of TIRF
buffer supplemented with 20 M taxol. The actin mix (0.6 M
actin, 30% Oregon Green 488-labeled, 3 M Chic, 
 4 nM
CapuCT, TIRF buffer, 20 M taxol, 500 g/ml glucose oxidase,
100 g/ml catalase, 500 g/ml  -casein) was flowed into the
cell and imaged after 3– 4 min of lag time. Images were col-
lected every 10 s on a DMI6000 TIRF microscope (Leica), using
a z penetration depth of 110 nm.
RESULTS
Microtubule Binding by Capu—We used high-speed taxol-
microtubule pelleting assays to measure microtubule binding
by the C-terminal half of Capu, CapuCT, comprising the two
conserved formin homology (FH) domains and short C-termi-
nal tail domain of Capu (see Fig. 1A for diagrams of core con-
structs used in this study). We fit our data to a non-cooperative,
polar, one-dimensional lattice binding model (20) to determine
the dissociation constant (Kd) and the number of 	/
-tubulin
dimers (n) in each binding site. At 50 mM KCl, CapuCT binds
microtubules with affinity on the order of 100 nM and occupies
a binding site of 	1.4 tubulin dimers (Fig. 1B and Table 1).
A previous study showed that the C-terminal tails of different
formins have varying effects on microtubule binding (4). We
therefore measured microtubule binding of CapuCTtail, a
construct lacking the 30-amino acid tail domain of Capu, and
found that the tail is required for microtubule binding (Fig. 1B).
To test tail-microtubule binding directly, we created a GST-
fusion protein of the tail domain of Capu because the orienta-
tion of the GST-tail dimer is thought to mimic the antiparallel
orientation of the formin dimer (4). Although GST-tail could
indeed bind microtubules, it bound with lower affinity (on the
order of 1 M) and higher binding density than CapuCT (	0.8
tubulin dimers per binding site; Fig. 1B and Table 1). GST bind-
ing to microtubules was negligible even at the highest protein
concentration used in these assays (Fig. 1B).
To further characterize the nature of Capu-microtubule
binding, we assessed the contribution of ionic contacts in the
microtubule pelleting assays. We first repeated the assay at a
higher ionic strength. At 100 mM KCl, CapuCT and GST-tail
both exhibit reduced microtubule binding density and binding
affinity (Fig. 1, C and D, and Table 1). Because the Capu-mi-
crotubule interaction is sensitive to salt, we next asked
whether the glutamate-rich C-terminal tails of 	- and 
-tubu-
lin are involved in Capu binding. We treated microtubules with
the protease subtilisin to selectively remove the acidic tubulin
tails. Similar to what we observed at higher ionic strengths, both
CapuCT and GST-tail exhibited reduced binding density and
TABLE 1
Fit parameters for all microtubule binding curves
The free energy of binding (rG) is expressed with units kJ/mol and the binding site
size (n) is expressed as the number of 	/
-tubulin dimers per binding site. Error bars
for rG and n represent one S.D. The most probable dissociation constant (Kd)
values are reported in units of M and calculated from rG at 25 °C (see “Experi-
mental Procedures” for additional information). Experiments performed with high
salt conditions (100 mM KCl) and/or subtilisin-treated microtubules (sMT) are
indicated; all other binding curves were measured at 50 mM KCl with untreated
microtubules.





 0.16 0.12 1.44 
 0.01
CapuCT  100 mM KCl 0.55 
 0.20 0.80 1.67 
 0.04
CapuCT  sMT 1.47 
 0.46 0.55 1.89 
 0.09
CapuCT  sMT  100 mM KCl 5.67 
 0.33 9.8 2.30 
 0.31
GST-tail 0.26 
 0.14 1.1 0.83 
 0.01
GST-tail  100 mM KCl 5.37 
 0.15 8.7 1.40 
 0.07
GST-tail  sMT 3.55 
 0.40 4.2 1.43 
 0.11
GST-tail  sMT  100 mM KCl 4.58 
 0.29 6.4 2.94 
 0.16
CapuCT-Scr 6.31 
 0.58 0.08 1.40 
 0.04
CapuCT-L1048A 5.56 
 0.10 0.11 1.35 
 0.01
CapuCT-I706A 4.71 
 0.25 0.15 1.41 
 0.02
CapuCT-D854N 5.66 
 0.29 0.10 1.44 
 0.02
CapuCT-K858A 4.01 
 0.17 0.20 1.20 
 0.01
CapuCT-K856A 3.33 
 0.11 0.26 0.83 
 0.01
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binding affinity to subtilisin-treated microtubules at 50 mM KCl
compared with untreated microtubules (Fig. 1, C and D, and
Table 1). Binding to subtilisin-treated microtubules was further
reduced at 100 mM KCl (Fig. 1, C and D, and Table 1), suggest-
ing that the tubulin tails are not the only sources of ionic
interaction.
Microtubules Inhibit Actin Nucleation Activity of Capu—Be-
cause Capu is a potent actin nucleator, we next asked whether
microtubule binding affects the ability of Capu to assemble
actin filaments. We first performed bulk pyrene-actin poly-
merization assays with A. castellani actin. In these assays, Capu
was preincubated with microtubules before being added to
actin. In these assays, microtubules inhibited actin assembly by
CapuCT in a dose-dependent manner (Fig. 2A). This effect is
specific to microtubules because CapuCT was only minimally
inhibited by a 40-fold molar excess of unassembled tubulin
dimers (Fig. 2D). Microtubules failed to inhibit CapuCTtail,
showing that inhibition requires high affinity microtubule
binding (Fig. 2E). We used higher concentrations of
CapuCTtail in this assay because this construct exhibits
reduced polymerization activity as reported previously (15).
We next tested whether this inhibitory effect persisted
when high levels of profilin were added to the assay. We used
S. pombe profilin in these assays because, unlike other profilins,
it exhibits minimal bias against binding actin labeled at Cys-374
(data not shown). Even in the presence of excess profilin (2:1
molar ratio with actin), microtubules inhibited CapuCT in a
dose-dependent manner (Fig. 2B). Profilin not only suppresses
formin nucleation activity but also works together with the FH1
domain to accelerate elongation of formin-bound filaments
(23, 24). We therefore used a Capu construct lacking the FH1
domain (CapuFH2; Fig. 1A) to specifically test nucleation inhi-
bition by microtubules in the presence of excess profilin.
Although nucleation by CapuFH2 was very slow in the presence
of profilin, microtubules further inhibited nucleation in a dose-
dependent manner (Fig. 2C).
To test whether microtubules were hindering the elongation
of Capu-associated filaments, we measured the effect of micro-
tubules added at different timepoints throughout the polymer-
ization assay. When we added microtubules immediately after
mixing CapuCT with actin, as opposed to before actin was
added, inhibition was dramatically reduced (Fig. 2F). Microtu-
bules added midway through the assay, when nucleation is neg-
ligible, had no noticeable inhibitory effect (Fig. 2F). These
results show that microtubules specifically inhibit the nucle-
ation activity of Capu and do not noticeably slow or inhibit the
elongation of Capu-associated actin filaments.
To gain a better mechanistic understanding of how micro-
tubules inhibit the nucleation activity of Capu, we tested
whether microtubules and actin monomers directly compete
for CapuCT binding. We first tried the same high-speed pellet-
ing assay conditions used by Gaillard et al. (4) to test actin
monomer competition with mDia1 and hINF2. Under these
assay conditions, a 10-fold molar excess of actin monomers, we
did not observe a change in CapuCT binding to microtubules in
the presence or absence of Drosophila profilin (Chic; Fig. 2G).
However, our bulk pyrene-actin polymerization assays contain
a much higher (400-fold) molar excess of actin monomers com-
pared with CapuCT. To better simulate the conditions of our
polymerization assay, we tried high-speed pelleting assays with
much lower and higher CapuCT and actin concentrations,
respectively. At a 200-fold molar excess of actin monomers,
	20% of the bound CapuCT was successfully competed away
from the microtubules (Fig. 2H). Together with our bulk
polymerization data, these findings suggest that microtubules
inhibit actin nucleation at least in part by preventing actin
monomers from associating with CapuCT.
Capu Association with the Barbed End of Actin Is Not Dis-
rupted by Microtubules—To better understand the interplay
between actin polymerization and microtubule binding, we
turned to single filament analysis. Using total internal reflection
fluorescence (TIRF) microscopy, we directly observed elongat-
ing actin filaments in a field of immobilized, taxol-stabilized
microtubules. To help limit the total number of actin filaments
in these assays, filaments were grown from preassembled F-ac-
FIGURE 1. High-affinity microtubule binding requires FH2 and tail. A,
schematics of Capu (1059 amino acids) and the constructs used in this paper.
CID, Capu inhibitory domain (orange); FH1, formin homology-1 (purple); FH2,
formin-homology-2 (blue); T, tail (red); GST (green). B, binding of CapuCT,
CapuCTtail, GST-tail, and GST control to taxol-stabilized microtubules at 50
mM KCl. Total tubulin concentration is 0.5 M in all binding assays. CapuCT (C)
and GST-tail (D) binding to intact microtubules at 50 mM KCl (solid circles, solid
line) or 100 mM KCl (open circles, dashed line) and to subtilisin-treated micro-
tubules (sMT) at 50 mM KCl (solid squares, solid line) or 100 mM KCl (open
squares, dashed line).
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tin seeds stabilized with Alexa Fluor 488-labeled phalloidin, and
CapuCT was added at very low concentrations. We included
Chic to differentiate filaments with Capu bound at the barbed
end from filaments free of Capu (19): in the presence of Chic,
Capu-associated filaments appear dimmer and elongate much
faster than bright Capu-free filaments.
In this experiment, elongating actin filaments that encoun-
tered a microtubule were observed to either cross over the
microtubule and continue growing (Fig. 3A, panel i, and
supplemental Movie S1); grow along the microtubule (Fig. 3A,
panel ii, and supplemental Movie S2); or turn away from the
microtubule and continue growing (Fig. 3A, panel iii, and sup-
plemental Movie S3). Consistent with our bulk polymerization
assays (Fig. 2F), CapuCT-associated filaments never stopped
upon encountering a microtubule. The frequencies of the three
observed behaviors were similar for both CapuCT-bound (dim)
and CapuCT-free (bright) filaments (Fig. 3B); we therefore
believe that these behaviors, although intriguing, reflect our
experimental set-up. The illumination field is deep enough (110
nm) to visualize filaments crossing without physically encoun-
tering each other. At the surface of the coverslip, microtubules
could act as physical barriers and cause actin filaments to turn
or elongate along the microtubule. Interactions between fluo-
rescent labels could also promote alignment of microtubules
and actin filaments.
Although CapuCT occasionally dissociated from the barbed
end of an actin filament upon encountering a microtubule (Fig.
3A, panel iv, and supplemental Movie S4), CapuCT remained
bound to the barbed end in 98% of all of the microtubule
encounters we observed (Fig. 3C). These data show directly that
microtubules are unable to effectively compete CapuCT away
from the barbed ends of actin filaments.
FIGURE 2. Microtubules potently inhibit nucleation activity of Capu. A, dose-dependent inhibition of 10 nM CapuCT by 10, 20, 50, and 100 nM microtubules
(MT) in bulk pyrene-actin polymerization assays. Microtubules do not affect baseline actin polymerization rates. B and C, microtubules inhibit nucleation from
profilin-actin by 10 nM CapuCT (B; 20, 50, 100, 200, and 500 nM microtubules) and 10 nM CapuFH2 lacking the FH1 domain (C; 20, 50, 100, 500 nM microtubules).
D, unassembled tubulin dimers have a negligible effect on CapuCT actin polymerization activity compared with taxol-stabilized microtubules. E, microtubules
do not inhibit actin polymerization by CapuCTtail. At a 10:1 molar ratio, microtubules potently inhibit actin polymerization by CapuCT but not CapuCTtail.
F, inhibition is sensitive to the time at which microtubules are added to the assay. Microtubules were added to CapuCT before adding actin (premixed),
immediately after adding actin (start), or 	120 s into the assay (mid, arrow indicates beginning of mixing; a.u., arbitrary units). G and H, LatB-stabilized actin
monomers (LatB-Actin; 2-fold molar excess of LatB) weakly compete with microtubules to bind CapuCT in high-speed pelleting assays. Pellet fractions are
shown, and concentrations are given. G, no noticeable competition was observed with 2.5 M LatB-actin in the absence or presence of Chic (Drosophila
profilin). H, some competition between microtubules and LatB-actin can be observed at very low CapuCT and very high LatB-actin concentrations, similar to
those used in bulk pyrene-actin nucleation assays. CapuCT bound to microtubules is reported as a percentage of the maximum CapuCT bound at 0 M
LatB-actin.
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Characterization of the Tail-Microtubule Interaction—We
attempted to map a more specific microtubule binding region
within the tail domain. In addition to microtubule binding, the
tail domain of Capu is involved in actin polymerization, pro-
tein-protein interactions, and autoinhibition (15, 19). A single
point mutation, L1048A, is sufficient to disrupt Capu binding to
the actin nucleator Spire (Spir) in vitro (15) but does not
decrease autoinhibition (19). This mutation had no effect on
microtubule binding (Fig. 4C and Table 1), suggesting that the
different functions of the tail domain of Capu may be separable.
We started by making a series of truncations and found that
CapuCT-microtubule binding decreased monotonically as the
tail was successively truncated (Fig. 4, A and B). From this, we
conclude that the microtubule-binding region cannot be read-
ily narrowed down to a small patch of neighboring residues
within the tail domain.
Our earlier experiments showed that microtubule binding by
Capu is sensitive to ionic strength and is therefore likely medi-
ated by charge-based interactions. Consistent with this hypoth-
esis, the tail domain of Capu is basic, with a theoretical pI of 11.7
(25) and a fairly even distribution of positively charged residues.
To test more directly whether positively charged residues
within the tail domain are important for microtubule binding,
we created several arginine/lysine-to-alanine double point
mutations (Fig. 4A). Despite being spread throughout the tail
domain of Capu, each set of mutations had a measurable and
approximately equal effect on microtubule binding (Fig. 4B).
These mutations also decreased the actin nucleation activity of
Capu (Fig. 4D), suggesting that Capu tail contributions to micro-
tubule binding and actin assembly are not readily separable.
Together with our truncation results, this point mutation
data suggested that the tail domain of Capu binds microtubules
through nonspecific charge-based interactions. To investigate
this further, we generated a CapuCT mutant in which the tail
residues were randomly scrambled to give a new sequence with
the same total charge and theoretical pI as the original
(CapuCT-Scr; Fig. 4C, Table 1). CapuCT-Scr bound microtu-
bules with comparable affinity and binding density to wild-type
CapuCT, further supporting our model that the Capu tail binds
microtubules nonspecifically. Interestingly, scrambling the tail
sequence of CapuCT did not diminish the actin nucleation
activity of CapuCT-Scr (Fig. 4D).
FH2 Domain Mutations Alter Microtubule Binding—Al-
though the tail domain of Capu is required for microtubule
binding, the differences in affinity and binding density between
CapuCT and GST-tail indicated that the FH2 domain also con-
tributes to microtubule binding. Because microtubules inhibit
the actin polymerization activity of Capu, we first mutated two
conserved actin binding residues in the FH2 domain of Capu
(I706A and K856A; see Fig. 6B) that are known to abolish actin
assembly activity in the yeast formin Bni1 (26). The I706A
mutation dramatically reduced the actin nucleation activity of
Capu but had little effect on microtubule binding (Fig. 5, A and
B, and Table 1). Unexpectedly, the K856A mutation had a neg-
ligible effect on actin nucleation activity but caused a noticeable
increase in microtubule binding density. The binding density of
CapuCT-K856A was intriguingly similar to that of GST-tail,
with an approximate binding site size of 0.8 tubulin dimers
versus 1.4 for wild-type CapuCT (Fig. 5, A and B, and Table 1).
Consistent with this, Capu-CT K856A is more sensitive to
microtubule inhibition than wild-type CapuCT in pyrene-actin
polymerization assays (Fig. 5C).
We next investigated whether other residues around Lys-856
are important for actin nucleation or microtubule binding.
First, we examined a point mutation (D854N; Fig. 6B) that we
identified by sequencing an EMS-generated capu mutant from
an earlier screen (16). Similar to I706A, this D854N mutation
had little effect on microtubule binding, but markedly
decreased the actin nucleation activity of Capu (Fig. 5, A and B,
and Table 1). In contrast to both D854N and K856A, mutating
a poorly conserved lysine residue (K858A; Fig. 6B) had little
effect on either actin nucleation activity or microtubule binding
(Fig. 5, A and B, and Table 1). Two additional mutants we
tested, K851A and K853A, were unstable in pelleting assays but
had robust actin nucleation activity. We indirectly tested
microtubule binding by these mutants by measuring sensitivity
to microtubule inhibition in bulk pyrene-actin polymerization
assays. Both mutants exhibited an increased sensitivity to
FIGURE 3. Microtubules do not disrupt Capu association with the barbed
end of actin. A, upon encountering a microtubule (magenta), elongating
actin filaments (green) either crossed the microtubule (i), tracked the micro-
tubule (ii), or turned at the microtubule (iii); occasionally CapuCT dissociated
from the barbed end upon encountering a microtubule (iv). Arrowheads
denote the barbed ends of interest, whereas arrows denote all of the other
barbed ends; free and CapuCT-associated barbed ends are represented by
open and filled symbols, respectively. Asterisks in the first panel denote bright,
Alexa Fluor 488-phalloidin-labeled F-actin seeds that were not nucleated by
CapuCT. Images are shown at 60-s intervals. Scale bar is 10 m. B, quantifica-
tion of actin behavior upon encountering microtubules in the presence or
absence of CapuCT. Events that could not be classified into one of these three
categories are reported as not determined (N.D.). C, quantification of micro-
tubule encounters that resulted in CapuCT dissociation from the barbed end
of an elongating actin filament (n  368; same data set as CapuCT in B).
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microtubule inhibition similar to CapuCT-K856A (Fig. 5C). As
a control, we also measured microtubule inhibition of CapuCT-
K858A and saw very little difference compared with wild-type
(Fig. 5C). From this, we concluded that microtubule binding is
mediated by specific residues within the FH2 domain and, unlike
binding by the tail domain, is not dependent on random charge-
based interactions. Therefore, although the tail domain is required
for high affinity binding, FH2 domain interactions are likely nec-
essary to properly orient Capu on the microtubule lattice.
DISCUSSION
Microtubule Binding—Based on structural information and
our experimental findings, we propose a simple model to
describe the mechanism of Capu-microtubule binding (Fig.
6C). A homology model of Capu based on the crystal structure
of hDAAM1 (27) reveals that residues within the FH2 domain
that affect microtubule binding (Lys-851, Lys-853, Lys-856) are
clustered into a positively charged patch near the base of the
Capu tail domain, suggesting that these regions form a contin-
uous binding surface (Fig. 6A). Negatively charged residues in
the patch (Asp-854) or positively charged residues located away
from the patch (Lys-858) have little or no effect on microtubule
binding. Capu binds microtubules through a seemingly syner-
gistic interaction involving both its tail and FH2 domains. The
FH2 domain alone is insufficient to measurably bind microtu-
bules in vitro, but the highly charged tail domain could act as an
electrostatic tether that promotes FH2 binding by increasing
the local FH2 concentration at the microtubule surface.
We further propose that the differences in microtubule bind-
ing density we observed reflect the size of the FH2 binding
footprint along the microtubule lattice: loss (GST-tail) or
reduction (K856A mutation) of FH2 domain binding results in
a smaller binding footprint and a corresponding increase in
binding density (Fig. 6C, panel i). This model could also explain
FIGURE 4. Tail binds microtubules through nonspecific charge-based interactions. A, sequences of wild-type and scrambled tail (residues 1029 –1059).
Residues mutated to alanine within wild-type are denoted by an asterisk. B, microtubule binding by CapuCT truncation and point mutation constructs.
Experimental conditions are 0.5 M tubulin and 2 M designated CapuCT construct in 50 mM KCl buffer. Individual experiments are plotted as dots with a line
showing the mean. C, CapuCT with a scrambled tail (CapuCT-Scr) or a Spir-binding point mutation (CapuCT-L1048A) bind microtubules comparably with
wild-type CapuCT. All binding assays are at 50 mM KCl with 0.5 M tubulin. D, actin polymerization activity of 10 nM each CapuCT tail point mutant and
CapuCT-Scr compared with wild-type (a.u., arbitrary units).
FIGURE 5. FH2 domain residues contribute to microtubule binding. A, microtubule binding by CapuCT-I706A, -D854N, -K858A, -K856A, and wild-type at 50
mM KCl with 0.5 M tubulin. B, actin polymerization activity of 10 nM each CapuCT FH2 mutant. C, CapuCT-K856A, but not CapuCT-K858A, is more sensitive to
microtubule inhibition than wild-type CapuCT. Two additional FH2 mutants, CapuCT-K851A and CapuCT-K853A, also exhibited increased sensitivity to
microtubule inhibition. For each construct, 10 nM was used and rates at the time until half-maximal polymerization (t1⁄2) were normalized to the maximum
polymerization rate (0 nM microtubules (MT)) and the baseline polymerization rate (actin) were reported in the Table inset (a.u., arbitrary units).
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the different microtubule binding densities seen among differ-
ent formins. An emerging trend shows that formins whose tails
can bind microtubules (Capu and mDia2) have higher binding
densities than formins whose tails do not bind microtubules
(mDia1 and hINF2) (4). In the absence of tail binding, formins
may rely on more extensive FH2 contacts with the microtubule
lattice and thus have a larger binding footprint.
Effect of Microtubules on Actin Assembly—Our data also sup-
port a model in which Capu does not simultaneously assemble
actin filaments and bind microtubules (Fig. 6C, panel ii). We
found that microtubules could potently inhibit the actin nucle-
ation activity of Capu in bulk assays but had little effect on Capu
once it was bound to the end of an elongating actin filament.
The location of residues Lys-851, Lys-853, and Lys-856 on our
homology model suggests that the FH2 domain binds both
microtubules and the actin barbed end through similar or over-
lapping surfaces, further supporting our model that microtu-
bules and actin barbed ends directly compete for Capu binding.
When Capu binds microtubules, its tail domain becomes
unavailable for actin monomer binding (15, 28) and the inner
FH2 domain becomes sterically occluded and inaccessible to
newly formed actin barbed ends. Conversely, the microtubule
binding surface in the FH2 domain is inaccessible when Capu is
associated with an actin barbed end, allowing Capu to elongate
actin filaments in the presence of microtubules.
Our TIRF microscopy assays provide additional insight into
important questions surrounding formin-mediated actin-mi-
crotubule cross-talk. Microtubules did not anchor elongating
actin filaments nor act as scaffolds for actin nucleation.
Although we did observe actin filaments tracking along micro-
tubules, this behavior was essentially the same in the presence
or absence of CapuCT, suggesting that low concentrations of
Capu do not actively align or bundle microtubules and actin
filaments. It was previously shown that Capu can cross-link
actin filaments and microtubules (7), most likely through side
binding of both microtubules and actin filaments. However, at
the very low CapuCT concentrations used in our TIRF assays,
we expect much of the CapuCT to be bound to the barbed end
of elongating filaments and unavailable for binding the sides of
actin filaments. Because of this, we were specifically testing the
relationship between microtubule and barbed end binding
rather than filament side binding.
Implications for the Role of Capu in Drosophila Oogenesis—
There is strong evidence that Capu helps build a cytoplasmic
actin mesh in the mid-stage Drosophila oocyte (29, 30). Here we
consider the role of Capu as both a microtubule binding protein
and actin assembly factor in the ooctye and how these functions
might be regulated. Our observation that actin barbed ends and
microtubules compete for Capu binding suggests that Capu
does not simultaneously bind microtubules and assemble actin
filaments within the oocyte. Acting as a microtubule binding
protein, Capu could directly regulate the microtubule cytoskel-
eton without invoking its actin assembly activity. It could cross-
link microtubules to each other and/or to pre-existing actin
filaments. Conversely, when assembling actin filaments and not
binding microtubules, Capu could still indirectly influence
microtubule organization through the actin cytoskeleton. Spa-
tial and/or temporal regulation of Capu could control when
FIGURE 6. Model of Capu-microtubule binding. A, expected locations of Capu FH2 mutations based on a Capu homology model. Residues are colored as in
B, and dashed lines represent the disordered C-terminal tail domains (residues 1037–1059). Homology model was generated from the hDAAM1 crystal structure
(Protein Data Bank code 2J1D (27)) using SWISS-MODEL (42). B, sequence alignments of several formins in the regions surrounding Ile-706 (green), Lys-851
(purple), Lys-853 (orange), Asp-854 (gold), Lys-856 (red), and Lys-858 (blue). Sequences were acquired from the NCBI Protein Database (Drosophila Capu,
NP_476966; mouse Fmn2, NP_062318; mouse Dia1, NP_031884; mouse Dia2, NP_062644; mouse Dia3, NP_766081; human INF2, NP_071934; human DAAM1,
NP_055807; Saccharomyces cerevisiae Bni1p, NP_014128) and aligned using ClustalW (21). The arrowhead denotes an mDia3 threonine residue shown previ-
ously to be phosphorylated by Aurora B kinase (31). C, schematic model for Capu-microtubule binding and actin-microtubule coordination. i, CapuCT binds
microtubules through both its FH2 and tail domains; changes in binding density reflect the level of contact between the FH2 domain and the microtubule
lattice. ii, actin barbed ends and microtubules compete for Capu binding; regulatory factors such as binding partners or post-translational modifications could
control the degree of actin versus microtubule binding in vivo.
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Capu is associated with microtubules versus actin filaments and
could be achieved through additional binding partners, post-
translational modification, or some combination thereof. For
instance, Capu binds the actin nucleator Spir through its tail
domain (15). Spir competes directly with microtubules for
Capu binding (13) and forms a functional nucleation unit when
bound to Capu (13, 15). This Spir-Capu nucleation unit may be
much more efficient at nucleating actin in the microtubule-rich
oocyte than Capu would be alone. Additional unidentified
binding partners may also play a role in regulating Capu asso-
ciation with microtubules. Several mammalian Diaphanous
family formins bind and/or colocalize with microtubule-asso-
ciated proteins such as EB1, APC, and CLIP-170 (31–33).
Future work will determine whether Capu has similar binding
partners within the Drosophila oocyte.
Post-translational modifications, especially phosphoryla-
tion, are commonly used to regulate microtubule binding by a
variety of microtubule-associated proteins (34, 35). With
respect to formins, mDia3 association with microtubules has
been shown to be mediated by phosphorylation by the Aurora B
kinase (31). Notably, one mDia3 phosphorylation site is con-
served across many formins and is within 10 amino acids of the
conserved Lys-856 residue of Capu (Fig. 6B). Moreover, lysine-
to-alanine mutations in this region of mDia1 have been shown
to disrupt actin-microtubule coordination in Hela cells (5), sug-
gesting that this region within the FH2 domain could be a
hotspot for microtubule binding among formins. Additionally,
we anticipate that post-translational modification within the
tail of Capu will be important for regulating Capu function in the
Drosophila oocyte. Although only 	30 amino acids long, the tail
domain is involved in Spir binding, microtubule binding, actin
nucleation, and Capu autoinhibition (15, 19). Such a promiscuous
domain will likely require careful regulation in vivo.
Finally, it is possible that microtubules themselves are a
means of regulating Capu activity in the oocyte. Throughout
mid and late oogenesis, microtubules are nucleated from all
regions of the oocyte cortex except the posterior pole (36), and
it was recently shown that Capu-dependent actin projections
emanate specifically from the posterior cortex of the oocyte
(37). Could microtubule organization restrict the location of
these Capu-dependent actin projections to the oocyte poste-
rior? Similarly, microtubules could tune the processivity of
Capu as it elongates actin filaments within the oocyte. Our
TIRF experiments show that microtubules do not effectively
compete Capu away from the barbed end of actin filaments,
causing barbed end dissociation in only 2% of all microtubule
encounters. However, this relatively low probability of dissoci-
ation could have a much more substantial effect over the span
of the entire oocyte where a single barbed end may encounter
hundreds of microtubules. Together with the autoinhibitory
activity of Capu (19), microtubules could also prevent Capu
from nucleating new actin filaments after falling off the end of
an elongating filament.
Concluding Remarks—Our results provide mechanistic
details of Capu-microtubule binding and the interplay of
microtubule binding and actin assembly in vitro. Beyond pro-
viding valuable insight into the role of Capu as a cytoskeletal
regulator in the Drosophila oocyte, these findings may help
advance our understanding of the Capu mammalian homologs,
Fmn-1 and Fmn-2. Capu FH2 residues 851– 856 are perfectly
conserved in Fmn-1 and Fmn-2, and both formins contain well
conserved, short, basic C-terminal tail domains, suggesting a
conserved mechanism for microtubule binding (13). These
formins have been implicated in a number of processes in a
wide variety of cell types, including intercellular adhesion and
cell spreading, as well as spindle positioning and cytokinesis
during mammalian oogenesis (10, 11, 38 – 41). How our find-
ings relate to the broader class of formin proteins remains to be
seen. Although the microtubule binding FH2 residues we iden-
tified are well conserved across several formin groups, the
C-terminal tail domains are more variable. Gaillard et al. (4)
recently showed that INF2, mDia1, and mDia2 have distinct
microtubule interaction properties. Notably, mDia2 has the
most basic tail of the three formins and behaves the most like
Capu in vitro. Future work will reveal whether our model for
Capu-microtubule binding can be generalized to other formins
such as mDia2.
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